This inventor holds 1 USPTO granted patent and 1 published patent application. Top assignee: Amgen Inc.. Active years: 2026.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2026
Title: The Innovations of Sharon Lynn Wannberg
Introduction
Sharon Lynn Wannberg is a notable inventor based in Thousand Oaks, CA (US). She has made significant contributions to the field of biomedical research, particularly in the development of therapeutic proteins. Her work focuses on innovative solutions for treating inflammatory diseases.
Latest Patents
Sharon holds 1 patent for her invention titled "IL-10 muteins and fusion proteins thereof." This patent relates to muteins of IL-10 that are stable as monomers, as well as antigen binding proteins that bind to TREM-1. The invention also includes methods for treating inflammatory diseases, such as inflammatory bowel disease or ulcerative colitis, using these compositions.
Career Highlights
Sharon is currently employed at Amgen Inc., a leading biotechnology company known for its innovative therapies. Her work at Amgen has allowed her to contribute to groundbreaking research and development in the field of medicine.
Collaborations
One of her notable coworkers is Ian Foltz, with whom she collaborates on various projects related to her research.
Conclusion
Sharon Lynn Wannberg's contributions to the field of biomedical research exemplify the impact of innovative thinking in developing treatments for complex diseases. Her work continues to inspire advancements in therapeutic solutions.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile